
Schrödinger
Develop, distribute, and apply advanced computational methods for pharma/chemical research501-1000 EmployeesActively Hiring
Jobs at Schrödinger
Schrödinger is on the cutting edge of computer-aided drug discovery and materials science. Our physics-based molecular simulation software continues to revolutionize the design of therapeutics and materials, helping researchers perform their work more rapidly, at a lower cost, and with a higher likelihood of success. FEP+, WaterMap, Glide, Maestro, and LiveDesign are just a few examples of the tools we’ve created. The Schrödinger platform integrates predictive physics-based methods with machine learning techniques to accelerate drug discovery. Our iterative process is designed to accelerate evaluation and optimization of chemical matter in silico ahead of synthesis and assay. The most promising compounds emerging from each round of experimental project chemistry are then further optimized through additional cycles of computation analysis. The result: our platform enables discovery of high-quality, novel molecules more rapidly, at lower cost, and we believe with a higher likelihood of success compared to traditional methods. While we license our software to industrial and academic researchers around the world, we also employ chemists, biologists, oncologists, and toxicologists to leverage the platform for internal discovery efforts. We have five wholly-owned drug discovery projects in our portfolio.